149 related articles for article (PubMed ID: 16452215)
1. Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zac1 expression.
Theodoropoulou M; Zhang J; Laupheimer S; Paez-Pereda M; Erneux C; Florio T; Pagotto U; Stalla GK
Cancer Res; 2006 Feb; 66(3):1576-82. PubMed ID: 16452215
[TBL] [Abstract][Full Text] [Related]
2. The somatostatin analogue octreotide confers sensitivity to rapamycin treatment on pituitary tumor cells.
Cerovac V; Monteserin-Garcia J; Rubinfeld H; Buchfelder M; Losa M; Florio T; Paez-Pereda M; Stalla GK; Theodoropoulou M
Cancer Res; 2010 Jan; 70(2):666-74. PubMed ID: 20068168
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activation of the mixed lineage leukemia-p27Kip1 pathway by a somatostatin analogue.
Horiguchi K; Yamada M; Satoh T; Hashimoto K; Hirato J; Tosaka M; Yamada S; Mori M
Clin Cancer Res; 2009 Apr; 15(8):2620-9. PubMed ID: 19318494
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells.
Hofland LJ; van Koetsveld PM; Wouters N; Waaijers M; Reubi JC; Lamberts SW
Endocrinology; 1992 Aug; 131(2):571-7. PubMed ID: 1322274
[TBL] [Abstract][Full Text] [Related]
5. ZAC1 target genes and pituitary tumorigenesis.
Theodoropoulou M; Stalla GK; Spengler D
Mol Cell Endocrinol; 2010 Sep; 326(1-2):60-5. PubMed ID: 20117169
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptors: from signaling to clinical practice.
Theodoropoulou M; Stalla GK
Front Neuroendocrinol; 2013 Aug; 34(3):228-52. PubMed ID: 23872332
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours.
Hubina E; Nanzer AM; Hanson MR; Ciccarelli E; Losa M; Gaia D; Papotti M; Terreni MR; Khalaf S; Jordan S; Czirják S; Hanzély Z; Nagy GM; Góth MI; Grossman AB; Korbonits M
Eur J Endocrinol; 2006 Aug; 155(2):371-9. PubMed ID: 16868153
[TBL] [Abstract][Full Text] [Related]
8. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.
Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Pattarozzi A; Bajetto A; Trapasso F; Fusco A; Schettini G
Mol Endocrinol; 2001 Oct; 15(10):1838-52. PubMed ID: 11579215
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of endothelin-1 gene expression by insulin via phosphoinositide-3 kinase-glycogen synthase kinase-3beta signaling in endothelial cells.
Yang Z; Li JC
Life Sci; 2008 Feb; 82(9-10):512-8. PubMed ID: 18201727
[TBL] [Abstract][Full Text] [Related]
10. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle.
Horn S; Endl E; Fehse B; Weck MM; Mayr GW; Jücker M
Leukemia; 2004 Nov; 18(11):1839-49. PubMed ID: 15457186
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.
Chahal HS; Trivellin G; Leontiou CA; Alband N; Fowkes RC; Tahir A; Igreja SC; Chapple JP; Jordan S; Lupp A; Schulz S; Ansorge O; Karavitaki N; Carlsen E; Wass JA; Grossman AB; Korbonits M
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1411-20. PubMed ID: 22659247
[TBL] [Abstract][Full Text] [Related]
12. Internalization of the radioiodinated somatostatin analog [125I-Tyr3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide.
Hofland LJ; van Koetsveld PM; Waaijers M; Zuyderwijk J; Breeman WA; Lamberts SW
Endocrinology; 1995 Sep; 136(9):3698-706. PubMed ID: 7649075
[TBL] [Abstract][Full Text] [Related]
13. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
[TBL] [Abstract][Full Text] [Related]
14. Regulation of glycogen synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma cells.
Dozza B; Smith MA; Perry G; Tabaton M; Strocchi P
J Neurochem; 2004 Jun; 89(5):1224-32. PubMed ID: 15147515
[TBL] [Abstract][Full Text] [Related]
15. Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2.
Ferrante E; Pellegrini C; Bondioni S; Peverelli E; Locatelli M; Gelmini P; Luciani P; Peri A; Mantovani G; Bosari S; Beck-Peccoz P; Spada A; Lania A
Endocr Relat Cancer; 2006 Sep; 13(3):955-62. PubMed ID: 16954443
[TBL] [Abstract][Full Text] [Related]
16. Cripto-1 induces phosphatidylinositol 3'-kinase-dependent phosphorylation of AKT and glycogen synthase kinase 3beta in human cervical carcinoma cells.
Ebert AD; Wechselberger C; Frank S; Wallace-Jones B; Seno M; Martinez-Lacaci I; Bianco C; De Santis M; Weitzel HK; Salomon DS
Cancer Res; 1999 Sep; 59(18):4502-5. PubMed ID: 10493495
[TBL] [Abstract][Full Text] [Related]
17. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
[TBL] [Abstract][Full Text] [Related]
18. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes.
Ugi S; Imamura T; Maegawa H; Egawa K; Yoshizaki T; Shi K; Obata T; Ebina Y; Kashiwagi A; Olefsky JM
Mol Cell Biol; 2004 Oct; 24(19):8778-89. PubMed ID: 15367694
[TBL] [Abstract][Full Text] [Related]
19. C-terminal fragment of tetanus toxin heavy chain activates Akt and MEK/ERK signalling pathways in a Trk receptor-dependent manner in cultured cortical neurons.
Gil C; Chaib-Oukadour I; Aguilera J
Biochem J; 2003 Jul; 373(Pt 2):613-20. PubMed ID: 12710887
[TBL] [Abstract][Full Text] [Related]
20. Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT/enhancer binding protein alpha by phosphatidylinositol 3-kinase signaling cascade.
Datta J; Majumder S; Kutay H; Motiwala T; Frankel W; Costa R; Cha HC; MacDougald OA; Jacob ST; Ghoshal K
Cancer Res; 2007 Mar; 67(6):2736-46. PubMed ID: 17363595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
